MedTrace Logo

Online Automated Self-Hypnosis Program

NCT03931772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2023-03-20

No results posted yet for this study

Summary

After developing professional quality materials (audio) for an affordable automated self-hypnosis intervention program for facilitating smoking cessation, stress and pain reduction, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation and reduction in pain and stress.

In addition, this study seeks to determine whether higher hypnotizability, as measured by the Hypnotic Induction Profile (assessed at baseline), is a moderator of improved outcome in these conditions.

Conditions

  • Smoking
  • Pain
  • Stress

Interventions

BEHAVIORAL

Automated Self-Hypnosis

Self-Hypnosis will be delivered through an interactive application administered through Amazon Alexa or Reveri.com.

Sponsors & Collaborators

Principal Investigators

  • David Spiegel, MD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2022-02-25
Completion
2022-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03931772 on ClinicalTrials.gov